Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EBIX
2176
DELISTED
Ebix Inc
EBIX
| $15M | ﹤0.01% |
441,176
+3,552
| +0.8% | +$110K |
|
2177
Sanofi
SNY
$103B
| $14.9M | ﹤0.01% |
283,778
+19,003
| +7% | +$992K |
|
2178
1st Source
SRCE
$2.18B
| $14.9M | ﹤0.01% |
321,190
+4,972
| +2% | +$238K |
|
|
VVNT
2179
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $14.9M | ﹤0.01% |
1,130,029
+148,791
| +15% | +$1.99M |
|
2180
Core Laboratories
CLB
$491M
| $14.9M | ﹤0.01% |
382,851
+22,373
| +6% | +$802K |
|
|
QUOT
2181
DELISTED
Quotient Technology Inc
QUOT
| $14.9M | ﹤0.01% |
1,376,836
+56,541
| +4% | +$755K |
|
2182
Perdoceo Education
PRDO
$2.04B
| $14.9M | ﹤0.01% |
1,212,778
+42,681
| +4% | +$522K |
|
2183
Standard Motor Products
SMP
$863M
| $14.8M | ﹤0.01% |
342,170
-1,384
| -0.4% | -$61.9K |
|
|
GDEN
2184
DELISTED
Golden Entertainment
GDEN
| $14.8M | ﹤0.01% |
330,969
+9,621
| +3% | +$368K |
|
2185
John B. Sanfilippo & Son
JBSS
$993M
| $14.8M | ﹤0.01% |
167,401
+5,926
| +4% | +$539K |
|
2186
OneSpan
OSPN
$588M
| $14.8M | ﹤0.01% |
578,652
+17,531
| +3% | +$458K |
|
2187
Warrior Met Coal
HCC
$4.25B
| $14.8M | ﹤0.01% |
858,688
+19,031
| +2% | +$332K |
|
2188
Preferred Bank
PFBC
$1.26B
| $14.8M | ﹤0.01% |
233,379
-3,756
| -2% | -$250K |
|
2189
RB Global
RBA
$20.9B
| $14.7M | ﹤0.01% |
249,300
+21,331
| +9% | +$1.31M |
|
2190
Collegium Pharmaceutical
COLL
$1.15B
| $14.7M | ﹤0.01% |
622,202
+35,927
| +6% | +$830K |
|
|
MGP
2191
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $14.7M | ﹤0.01% |
401,095
+4,916
| +1% | +$175K |
|
2192
OrthoPediatrics
KIDS
$536M
| $14.7M | ﹤0.01% |
232,382
+10,501
| +5% | +$603K |
|
2193
Travere Therapeutics
TVTX
$5.11B
| $14.7M | ﹤0.01% |
1,005,439
+48,193
| +5% | +$951K |
|
2194
Kelly Services Class A
KELYA
$520M
| $14.6M | ﹤0.01% |
608,934
+22,584
| +4% | +$558K |
|
2195
MediaAlpha
MAX
$781M
| $14.6M | ﹤0.01% |
346,474
+80,959
| +30% | +$3.24M |
|
|
CUTR
2196
DELISTED
Cutera, Inc.
CUTR
| $14.6M | ﹤0.01% |
297,137
+8,437
| +3% | +$310K |
|
2197
Photronics
PLAB
$1.85B
| $14.5M | ﹤0.01% |
1,101,267
+34,136
| +3% | +$446K |
|
2198
Atea Pharmaceuticals
AVIR
$369M
| $14.5M | ﹤0.01% |
677,053
+402,168
| +146% | +$12.1M |
|
2199
Enanta Pharmaceuticals
ENTA
$377M
| $14.5M | ﹤0.01% |
330,409
+17,865
| +6% | +$875K |
|
2200
Heartland Express
HTLD
$949M
| $14.5M | ﹤0.01% |
847,647
+22,082
| +3% | +$408K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.